Abstracts tagged "opioids"

Abstract Number: 1064 • ACR Convergence 2021
Pharmacist-Led Multidisciplinary Approach to Opioid Tapering in a Private Rheumatology Practice: Patient Outcomes
Jessica Farrell¹, Mitchell Miller², Kelsey Hennig³, Kaitlyn McCarthy⁴, Christ Ange Katche⁵ and Jacqueline Cleary⁶, ¹Albany College of Pharmacy and Health Sciences, Steffens Scleroderma Foundation, Albany, NY, ²Bassett Medical Center, Albany, NY, ³Binghamton University, New Lebanon, NY, ⁴Center for Rheumatology, Albany, NY, ⁵Albany College of Pharmacy & Health Sciences, Guilderland, NY, ⁶Albany College of Pharmacy & Health Sciences, Albany, NY
Background/Purpose: With the evolution of disease modifying anti-rheumatic drugs medications, the need for opioids in the treatment of rheumatic diseases has decreased. However, rheumatology professionals…
Abstract Number: 1777 • ACR Convergence 2021
Association of Opioid Use and Opioid-Related Costs with Patient-Reported Outcomes in Patients with Psoriatic Arthritis or Ankylosing Spondylitis
Alexis Ogdie-Beatty¹, Mark Hwang², Phani Veeranki³, Alexandria Portelli³, Jason Shafrin³, Sofia Pedro⁴, Esther Yi⁵, Steven Hass⁶ and Kaleb Michaud⁷, ¹University of Pennsylvania, Philadelphia, PA, ²McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, ³PRECISIONheor, Los Angeles, CA, ⁴Forward, The National Databank for Rheumatic Diseases, Wichita, KS, ⁵Novartis Pharmaceuticals Corporation, Weehawken, NJ, ⁶H.E. Outcomes, LLC, Los Angeles, CA, ⁷University of Nebraska Medical Center, Omaha, NE
Background/Purpose: Patients with psoriatic arthritis (PsA) or ankylosing spondylitis (AS) experience chronic pain due to inflammatory attributes of their disease. Nonsteroidal anti‑inflammatory drugs and biologics…
Abstract Number: 954 • ACR/ARP Annual Meeting 2019
Physical Therapy and Opioid Use in Knee Osteoarthritis
Deepak Kumar¹, Christine Peloquin ², Andrew Stokes ³, Lee Marinko ⁴, James Camarinos ⁴, David Felson ⁵ and Maureen Dubreuil ², ¹Boston University, Boston, MA, ²Boston University School of Medicine, Boston, ³Boston University School of Public Health, Boston, ⁴Boston University, Boston, ⁵Boston University School of Medicine, Department of Rheumatology, Boston
Background/Purpose: Knee osteoarthritis (OA) is a leading cause of chronic pain in older adults. Physical therapy (PT) decreases OA pain and consequently may reduce burden…
Abstract Number: 1097 • ACR/ARP Annual Meeting 2019
Trends in NSAIDs and Opioids Among Patients with SLE: A Population-based Study
Lingyi Li¹, Na Lu ¹, Jacek Kopec ², John Esdaile ³, Hui Xie ⁴ and J. Antonio Avina-Zubieta ², ¹Arthritis Research Canada, Vancouver, BC, Canada, ²Arthritis Research Canada and the University of British Columbia, Vancouver, BC, Canada, ³Arthritis Research Canada and the University of British Columbia, Richmond, BC, Canada, ⁴Arthritis Research Canada and Simon Fraser University, Vancouver, BC, Canada
Background/Purpose: Non-steroidal anti-inflammatory drugs (NSAIDs) and opioids are prescribed for the management of pain among patients with rheumatic diseases including systemic lupus erythematosus (SLE). However,…
Abstract Number: 1129 • ACR/ARP Annual Meeting 2019
Direct Medical and Societal Cost of Opioid Use in Symptomatic Knee Osteoarthritis Patients in the United States
Jamie Huizinga¹, Elizabeth Stanley ¹, Shuang Song ¹, James Sullivan ², Jeffrey Katz ³ and Elena Losina ⁴, ¹Brigham and Women's Hospital, Boston, MA, ²Brigham and Women's Hospital, Boston, ³Brigham and Women's Hospital/Harvard Medical School, Boston, ⁴Brigham and Women's Hospital and Harvard Medical School, Boston, MA
Background/Purpose: Symptomatic knee OA affects 14 million adults in the US. Recent estimates suggest that about 40% of people with knee OA are taking prescription…
Abstract Number: 1880 • ACR/ARP Annual Meeting 2019
Baricitinib 4 Mg and 2 Mg Once Daily Reduced Pain in Both Patients Who Were Opioid Users and Non-users in Active Rheumatoid Arthritis: A Post-hoc Analysis of Phase 3 Trials
Janet Pope¹, Yvonne Lee ², Jeffrey Curtis ³, Daojun Mo ⁴, Terence Rooney ⁴, Li Xie ⁴, Christina Dickson ⁴, Douglas Schlichting ⁴, Amanda Quebe ⁴, Anabela Cardoso ⁴, Lee Simon ⁵ and Peter Taylor ⁶, ¹Western University, London, ON, Canada, ²Northwestern University Feinberg School of Medicine, Chicago, ³University of Alabama at Birmingham, Birmingham, AL, ⁴Eli Lilly and Company, Indianapolis, IN, ⁵SDG LLC, Cambridge, MA, ⁶University of Oxford, Oxford, United Kingdom
Background/Purpose: Opioid use in RA patients has increased over the past 2 decades in the US. Little is known about the combined effects of opioids…
Abstract Number: 2047 • ACR/ARP Annual Meeting 2019
Time-trends in Opioid Use Hospitalizations in Common Musculoskeletal Conditions: Gout, Osteoarthritis, Rheumatoid Arthritis, Fibromyalgia, and Low Back Pain
Jasvinder Singh¹ and John Cleveland ², ¹University of Alabama Medical Center, Birmingham, ²University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Rates of opioid abuse and associated mortality is a problem of epidemic proportion in the U.S. To our knowledge, limited data are available on…
Abstract Number: 2048 • ACR/ARP Annual Meeting 2019
Opioid Prescription Use Among Patients with Rheumatic Disease: A Population Based Cohort Study
April Jorge¹, Na Lu ² and Hyon K. Choi ¹, ¹Massachusetts General Hospital, Boston, MA, ²Massachusetts General Hosptial, Boston, MA
Background/Purpose: Rheumatic diseases can be associated with pain and disability. An international opioid epidemic is ongoing, and prescription opioid use has been linked with increased…
Abstract Number: 2076 • ACR/ARP Annual Meeting 2019
The Opioid Epidemic: The Rheumatology Response to Management of Chronic Pain
Michael Grant¹, Alysia Kwiatkowski ¹ and Najia Shakoor ¹, ¹Rush University Medical Center, Chicago, IL
Background/Purpose: Pain is the hallmark symptom of many rheumatologic conditions and chronic pain management is a major part of clinical practice in rheumatology. Therefore, as…
Abstract Number: 2553 • ACR/ARP Annual Meeting 2019
Prescription Opioid Use and Osteoporotic Fractures in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology & Surveillance (MILES) Cohort
Emily Somers¹, Sioban Harlow ¹, Nina Zhou ¹, Lu Wang ¹, Kamil Barbour ², Charles Helmick ³, Caroline Gordon ⁴, Deeba Minhas ¹, Beth Wallace ¹, Afton Hassett ¹, Suzanna Zick ¹, W. Joseph McCune ⁵ and Wendy Marder ¹, ¹University of Michigan, Ann Arbor, ²Centers for Disease Control and Prevention, Atlanta, ³Centers for Disease Control and Prevention, Division of Population Health, Atlanta, GA, ⁴University of Birmingham, Birmingham, United Kingdom, ⁵University of Michigan, Ann Arbor, MI
Background/Purpose: We recently reported prescription opioid use in nearly one-third of systemic lupus erythematosus (SLE) patients in our population-based cohort. Data suggest that opioids may…
Abstract Number: 2566 • ACR/ARP Annual Meeting 2019
Polypharmacy and Potentially Inappropriate Medication Use in Young versus Older Adults with SLE
Dale Seguin¹, Christine Peschken ², Casandra Dolovich ¹, Ruby Grymonpre ¹, Phil St. John ¹ and Annaliese Tisseverasinghe ¹, ¹University of Manitoba, Winnipeg, MB, Canada, ²University of Manitoba, Winnipeg, Canada
Background/Purpose: Polypharmacy, typically defined as ≥ 5 medications (meds), is a strong risk factor for adverse clinical outcomes, including delirium, falls, hospitalization, and death, especially…
Abstract Number: 2891 • ACR/ARP Annual Meeting 2019
Cost-effectiveness of Duloxetine for Knee OA Patients Whose Pain Can’t Be Controlled by NSAIDs
James Sullivan¹, Jeffrey Katz ² and Elena Losina ³, ¹Brigham and Women's Hospital, Boston, ²Brigham and Women's Hospital/Harvard Medical School, Boston, ³Brigham and Women's Hospital and Harvard Medical School, Boston, MA
Background/Purpose: Knee OA is a disabling condition affecting over 14 million adults in the US. NSAIDs provide only short-term pain relief, creating the need for…
Abstract Number: 215 • ACR/ARP Annual Meeting 2019
Opioid Treatment Pattern in a Community Based Rheumatology Clinic
Reema Andrade¹, Paula Roe - Prior ², Oanh Doan ² and Julio Ramos ², ¹The Wright Center For Graduate Medical Education, Crofton, MD, ²The Wright Center For Graduate Medical Education, Scranton, PA
Background/Purpose: Rheumatologic pain, especially fibromyalgia, is difficult to treat. While Nonsteroidal anti-inflammatory drugs (NSAIDs) are traditionally prescribed as the first line treatment for fibromyalgia, when…
Abstract Number: 274 • ACR/ARP Annual Meeting 2019
Participation in the Stanford University Chronic Pain Self-Management Program in a Population with a High Prevalence of Arthritis
Dina Jones¹, Louise Murphy ², Ranjita Misra ¹, Alison Vargovich ³, Dana Guglielmo ⁴, Maura Robinson ¹, Samantha Shawley-Brzoska ¹, Sijin Wen ¹, Megan Burkart ¹ and Richard Vaglienti ¹, ¹West Virginia University, Morgantown, WV, ²Centers for Disease Control and Prevention, Division of Population Health, Atlanta, ³University at Buffalo - SUNY, Buffalo, NY, ⁴Centers for Disease Control and Prevention, Division of Population Health, Atlanta, GA
Background/Purpose: In 2016, 1 in 5 US adults reported chronic pain (CP). Osteoarthritis and rheumatoid arthritis are top causes of CP. The Stanford University Chronic…
Abstract Number: 354 • ACR/ARP Annual Meeting 2019
Evaluation of Opioid Analgesia in Hospitalized Patients with Acute Crystal Induced Arthritis
Sukhraj Singh¹, Anthony Ocon ¹, Mark Riley ², Jennifer Tchervenkov ¹ and Ruben Peredo-Wende ¹, ¹Albany Medical Center, Albany, NY, ²Albany Medical Center, Albany
Background/Purpose: The Opioid Epidemic has been declared a public health emergency since 2017. The use of opioids in the acute crystal induced arthritis (ACIA) population…